GlassScriptPhysician profile
Michael Callegari
NPI 1124524079
$52,789.70
in general payments reported to CMS, 2019-2025
14 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $310 · 2022: $221 · 2023: $200 · 2024: $52K · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Travel and Lodging: $1,107 · Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Travel and Lodging | $1,106.54 |
| Food and Beverage | $1,038.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,160.81 | 2019-2025 | Ams 700, Tactra, Lithovue |
| Convatec INC. | $140.07 | 2023-2025 | |
| Baxter Healthcare | $120.71 | 2021 | |
| Urogen Pharma, INC. | $103.85 | 2021 | |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Becton, Dickinson and Company | $41.56 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $36.81 | 2025 | Gemtesa |
| Endo USA, INC. | $25.99 | 2025 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $23.44 | 2019 | |
| Abc Home Medical Supply, INC. | $20.25 | 2025 | |
| Laborie Medical Technologies Corp. | $19.14 | 2025 | |
| Medical Device Business Services, INC. | $19.09 | 2024 | Echelon Flex |
| Photocure INC | $14.99 | 2025 | Cysview |
| Myovant Sciences INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Callegari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.